Search research articles
Contact Us
Filters
Showing results (801-810 of 1,011) with videos related to
Page
of 102
Sort By:
The New England Journal of Medicine
|
November 9, 2012
Progression of RAS-mutant leukemia during RAF inhibitor treatment
Margaret K Callahan, Raajit Rampal, James J Harding, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 19, 2015
Long-term outcome in BRAF(V600E) melanoma patients treated with vemurafenib: Patterns of disease progression and clinical management of limited progression
Igor Puzanov, Ravi K Amaravadi, Grant A McArthur, et al.
Melanoma Research
|
January 23, 2016
A phase 2 trial of everolimus and pasireotide long-acting release in patients with metastatic uveal melanoma
Alexander N Shoushtari, Leonard T Ong, Heiko Schoder, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
November 29, 2005
Sonographic assessment of the severity and progression of autosomal dominant polycystic kidney disease: the Consortium of Renal Imaging Studies in Polycystic Kidney Disease (CRISP)
W Charles O'Neill, Michelle L Robbin, Kyongtae T Bae, et al.
Kidney International
|
April 2, 2015
A comparison of ultrasound and magnetic resonance imaging shows that kidney length predicts chronic kidney disease in autosomal dominant polycystic kidney disease
Harpreet Bhutani, Vikram Smith, Frederic Rahbari-Oskoui, et al.
Cancer
|
April 30, 2005
Temozolomide plus thalidomide in patients with brain metastases from melanoma: a phase II study
Wen-Jen Hwu, Eric Lis, Jennifer H Menell, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
December 21, 2005
Phase 2 study of the g209-2M melanoma peptide vaccine and low-dose interleukin-2 in advanced melanoma: Cancer and Leukemia Group B 509901
John D Roberts, Donna Niedzwiecki, William E Carson, et al.
American Journal of Nephrology
|
March 1, 2014
Novel methodology to evaluate renal cysts in polycystic kidney disease
Kyongtae T Bae, Hongliang Sun, June Goo Lee, et al.
Metabolic Syndrome and Related Disorders
|
February 10, 2015
Association of branched and aromatic amino acids levels with metabolic syndrome and impaired fasting glucose in hypertensive patients
Liming Weng, Eoin Quinlivan, Yan Gong, et al.
Annals of Surgical Oncology
|
December 19, 2019
Survival Outcomes After Metastasectomy in Melanoma Patients Categorized by Response to Checkpoint Blockade
Danielle M Bello, Katherine S Panageas, Travis Hollmann, et al.
Page
of 102
Search research articles
Search
Showing results (801-810 of 1,011) with videos related to
Sort By:
Page
of 102
The New England Journal of Medicine
|
November 9, 2012
Progression of RAS-mutant leukemia during RAF inhibitor treatment
Margaret K Callahan, Raajit Rampal, James J Harding, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 19, 2015
Long-term outcome in BRAF(V600E) melanoma patients treated with vemurafenib: Patterns of disease progression and clinical management of limited progression
Igor Puzanov, Ravi K Amaravadi, Grant A McArthur, et al.
Melanoma Research
|
January 23, 2016
A phase 2 trial of everolimus and pasireotide long-acting release in patients with metastatic uveal melanoma
Alexander N Shoushtari, Leonard T Ong, Heiko Schoder, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
November 29, 2005
Sonographic assessment of the severity and progression of autosomal dominant polycystic kidney disease: the Consortium of Renal Imaging Studies in Polycystic Kidney Disease (CRISP)
W Charles O'Neill, Michelle L Robbin, Kyongtae T Bae, et al.
Kidney International
|
April 2, 2015
A comparison of ultrasound and magnetic resonance imaging shows that kidney length predicts chronic kidney disease in autosomal dominant polycystic kidney disease
Harpreet Bhutani, Vikram Smith, Frederic Rahbari-Oskoui, et al.
Cancer
|
April 30, 2005
Temozolomide plus thalidomide in patients with brain metastases from melanoma: a phase II study
Wen-Jen Hwu, Eric Lis, Jennifer H Menell, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
December 21, 2005
Phase 2 study of the g209-2M melanoma peptide vaccine and low-dose interleukin-2 in advanced melanoma: Cancer and Leukemia Group B 509901
John D Roberts, Donna Niedzwiecki, William E Carson, et al.
American Journal of Nephrology
|
March 1, 2014
Novel methodology to evaluate renal cysts in polycystic kidney disease
Kyongtae T Bae, Hongliang Sun, June Goo Lee, et al.
Metabolic Syndrome and Related Disorders
|
February 10, 2015
Association of branched and aromatic amino acids levels with metabolic syndrome and impaired fasting glucose in hypertensive patients
Liming Weng, Eoin Quinlivan, Yan Gong, et al.
Annals of Surgical Oncology
|
December 19, 2019
Survival Outcomes After Metastasectomy in Melanoma Patients Categorized by Response to Checkpoint Blockade
Danielle M Bello, Katherine S Panageas, Travis Hollmann, et al.
Page
of 102